This inventor holds 2 USPTO granted patents. Top assignees: Aventis Pharma Deutschland, Gmbh, Hoechst Aktiengesellschaft. Active years: 1999-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 330 
1 out of 6,705 
Years Active: 1999-2000
Title: Martin Schonharting: Innovator in Immunological Treatments
Introduction
Martin Schonharting is a notable inventor based in Taunusstein, Germany. He has made significant contributions to the field of immunology through his innovative research and development. With a total of 2 patents, Schonharting has focused on creating effective treatments for immunological diseases.
Latest Patents
His latest patents include a combination preparation containing cyclosporin A or FK506 or rapamycin. Additionally, he has developed a combination preparation specifically for use in immunological diseases. These inventions highlight his commitment to advancing medical treatments and improving patient outcomes.
Career Highlights
Throughout his career, Martin Schonharting has worked with prominent companies in the pharmaceutical industry. He has been associated with Hoechst Aktiengesellschaft and Aventis Pharma Deutschland GmbH. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research.
Collaborations
Schonharting has collaborated with esteemed colleagues, including Stefan Mullner and Peter Zabel. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Martin Schonharting's work in immunological treatments exemplifies the impact of dedicated inventors in the medical field. His patents and collaborations reflect a commitment to improving health outcomes through innovative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile